Skip to main content

Table 4 Clinical characteristics of renal flares

From: Clinical and immunological biomarkers can identify proliferative changes and predict renal flares in lupus nephritis

Pts

Histological class

Type of flare

Nephritic 1

Proteinuric 2

Therapy at flare

Time to renal flare months

Serum creatinine mg/dl

Proteinuria g/24H

Number of red blood cells /high power field at urinary sediment

Pre flare

At flare

At last observation

Pre flare

At flare

At last observation

Pre flare

At flare

At last observation

1

V

2

Pr. 5 mg, Tacr 3 mg, MMF 750 mg

24.0

0.68

0.71

0.80

0.34

1.6

0.13

0

0

0

2

IV

2

Pr.5 mg,

MMF 1 gr

42.9

0.92

0.86

0.85

0.15

1.6

0.11

0

12

0

3

IV + V

1

Pr. 10 mg

Neoral 75 mg

55.8

0.76

1.23

0.90

0.26

0.93

0.72

0

35

0

4

IV

2

Pr 6.25 mg

MMF 3gr

28.7

0.85

0.9

0.95

0.24

2.3

1.20

2

7

4

5

IV

2

Pr 12.5 mg

MMF 2gr

16.3

0.72

0.88

0.89

0.85

5.1

0.15

2

8

0

6

IV

1

Pr 5 mg

MMF 2gr

28.1

0.65

1.1

0.70

0.18

0.9

0.05

5

20

0

7

IV + V

2

Pr 5 mg

MMF 1.5gr

26.2

0.46

0.57

0.54

0.29

1.6

0.16

0

0

0

8

III + V

2

Pr 6.25 mg

Tacr 3 mg

28.3

0.89

0.91

0.75

0.28

1.4

0.42

6

2

0

9

III + V

2

Pr 3.75 mg

MMF 1gr

14.5

1.09

1.03

1.30

0.27

1.05

0.20

2

12

0

10

III

1

Pr 6.25 mg

Neoral 100 mg

49.9

0.74

1.0

0.70

0.14

1.2

0.34

0

20

1

  1. Legend: Pr: prednisone; MMF, Mycophenolate mofetil; Tacr: tacrolimus